false
Skip Navigation Links
Home
About SSO
ASO Article Search
COVID-19 Resources
SSO Website
Menu
Home
About SSO
ASO Article Search
COVID-19 Resources
SSO Website
Hamburger Menu
Catalog
The Choice of Neoadjuvant Therapy for Hormone Rece ...
The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer
Activity Description
In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma.
These episodes are based upon the SSO educational session that was conducted during the 2019 San Antonio Breast Cancer Symposium® (SABCS®) titled,
Multidisciplinary Approach to Optimizing Local Regional Therapy in Hormone Receptor Positive Breast Cancer.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Forgot Password
×
Please select your language
1
English